40.4: Blood Flow and Blood Pressure Regulation - Biology

40.4:  Blood Flow and Blood Pressure Regulation - Biology

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

40.4: Blood Flow and Blood Pressure Regulation

40.4 Blood flow and blood pressure regulation

Blood pressure (BP) is the pressure exerted by blood on the walls of a blood vessel that helps to push blood through the body. Systolic blood pressure measures the amount of pressure that blood exerts on vessels while the heart is beating. The optimal systolic blood pressure is 120 mmHg. Diastolic blood pressure measures the pressure in the vessels between heartbeats. The optimal diastolic blood pressure is 80 mmHg. Many factors can affect blood pressure, such as hormones, stress, exercise, eating, sitting, and standing. Blood flow through the body is regulated by the size of blood vessels, by the action of smooth muscle, by one-way valves, and by the fluid pressure of the blood itself.

Link to learning

Visit this site to see the circulatory system&rsquos blood flow.

Proteins and other large solutes cannot leave the capillaries. The loss of the watery plasma creates a hyperosmotic solution within the capillaries, especially near the venules. This causes about 85% of the plasma that leaves the capillaries to eventually diffuses back into the capillaries near the venules. The remaining 15% of blood plasma drains out from the interstitial fluid into nearby lymphatic vessels ( [link] ). The fluid in the lymph is similar in composition to the interstitial fluid. The lymph fluid passes through lymph nodes before it returns to the heart via the vena cava. Lymph nodes are specialized organs that filter the lymph by percolation through a maze of connective tissue filled with white blood cells. The white blood cells remove infectious agents, such as bacteria and viruses, to clean the lymph before it returns to the bloodstream. After it is cleaned, the lymph returns to the heart by the action of smooth muscle pumping, skeletal muscle action, and one-way valves joining the returning blood near the junction of the venae cavae entering the right atrium of the heart.

Fluid from the capillaries moves into the interstitial space and lymph capillaries by diffusion down a pressure gradient and also by osmosis. Out of 7,200 liters of fluid pumped by the average heart in a day, over 1,500 liters is filtered. (credit: modification of work by NCI, NIH)

Please follow the instructions below to begin the experiment.

  1. How to measure the blood pressure.
    -You need stethoscope and sphygmomanometer to conduct the experiment.
    -Read the manual of blood pressure background,palpation and auscultation and
    -watch the video before practicing.
  2. Virtual microscope slide by Peter Takizawa.
    Read the blood cells manual and observe the following blood cells:
  1. Study the Heart Model slides below and identify their structures.

What types of blood cells in this blood smear?
View the slide at 400x magnification, and identify the cells pointed by red pins.
(Histology at Yale)

Adaptive changes in renal vasculature

The primary adaptive mechanism in pregnancy is a marked fall in systemic vascular resistance (SVR) occurring by week six of gestation. The 40% fall in SVR also affects the renal vasculature.4 Despite a major increase in plasma volume during pregnancy, the massive decrease in SVR creates a state of arterial under-filling because 85% of the volume resides in the venous circulation.5 This arterial under-filling state is unique to pregnancy. The fall in SVR is combined with increased renal blood flow and this is in contrast to other states of arterial under-filling, such as cirrhosis, sepsis or arterio-venous fistulas.3,6

Relaxin, a peptide hormone produced by the corpus luteum, decidua and placenta, plays an important role in the regulation of haemodynamic and water metabolism during pregnancy. Serum concentrations of relaxin, already elevated in the luteal phase of the menstrual cycle, rise after conception to a peak at the end of the first trimester and fall to an intermediate value throughout the second and third trimester. Relaxin stimulates the formation of endothelin, which in turn mediates vasodilation of renal arteries via nitric oxide (NO) synthesis.7

Despite activation of the renin𠄺ngiotensin𠄺ldosterone (RAA) system in early pregnancy, a simultaneous relative resistance to angiotensin II develops, counterbalancing the vasoconstrictive effect and allowing profound vasodilatation.8 This insensitivity to angiotensin II may be explained by the effects of progesterone and vascular endothelial growth factormediated prostacyclin production, as well as modifications in the angiotensin I receptors during pregnancy.9 The vascular refractoriness to angiotensin II may also be shared by other vasoconstrictors such as adrenergic agonists and arginine vasopressin (AVP).10 It is possible that in the second half of pregnancy, the placental vasodilatators are more important in the maintenance of the vasodilatatory state.6


Obesity has become an increasingly important medical problem in children and adolescents. In national surveys from the 1960s to the 1990s, the prevalence of overweight in children grew from 5% to 11%. Outcomes related to childhood obesity include hypertension, type 2 diabetes mellitus, dyslipidemia, left ventricular hypertrophy, nonalcoholic steatohepatitis, obstructive sleep apnea, orthopedic problems, and psychosocial problems. Once considered rare, primary hypertension in children has become increasingly common in association with obesity and other risk factors, including a family history of hypertension and an ethnic predisposition to hypertensive disease. Obese children are at approximately a 3-fold higher risk for hypertension than nonobese children. In addition, the risk of hypertension in children increases across the entire range of body mass index (BMI) values and is not defined by a simple threshold effect. As in adults, a combination of factors including overactivity of the sympathetic nervous system (SNS), insulin resistance, and abnormalities in vascular structure and function may contribute to obesity-related hypertension in children. The benefits of weight loss for blood pressure reduction in children have been demonstrated in both observational and interventional studies. Obesity in childhood should be considered a chronic medical condition that is likely to require long-term management. Ultimately, prevention of obesity and its complications, including hypertension, is the goal.

Obesity has become an increasingly important medical problem in children and adolescents. Many of the outcomes associated with obesity that were previously thought of as diseases of adults are now affecting children as well. Outcomes related to childhood obesity include hypertension, type 2 diabetes mellitus, dyslipidemia, left ventricular hypertrophy, nonalcoholic steatohepatitis, obstructive sleep apnea, and orthopedic problems (such as slipped capital-femoral epiphysis), as well as social and psychological problems. 1 Obesity is also the most common nutritional problem among children in developed countries. This epidemic of pediatric obesity has resulted in great concern regarding the management of obesity and its complications. Although prevention would be an optimum strategy, it may be difficult to identify children at risk of obesity before they become overweight. Even with appropriate preventive approaches, it is likely that many children will become overweight and require treatment to prevent the long-term sequelae of obesity, such as cardiovascular morbidity and mortality. 2

In concert with the increasing prevalence of obesity in children, pediatric hypertension has undergone an epidemiological shift. The conventional wisdom has been that hypertension in children is a relatively rare condition most commonly associated with renal disease. In actuality, secondary hypertension in children resulting from renal disease has become far less common than that related to primary (ie, essential) hypertension. In a large pediatric hypertension practice, the typical patient demographic has evolved into an otherwise healthy adolescent with obesity and some combination of the cardiovascular risk factors associated with obesity, including a family history of hypertension and an ethnic predisposition to hypertensive disease. The general topic of obesity hypertension has previously undergone comprehensive review. 3 The goal of this current review will be to focus specifically on available data on the epidemiology, pathophysiology, sequelae, and management of obesity-related hypertension in children.


In the United States, the prevalence and severity of overweight status is clearly increasing among children. In national surveys from the 1960s to the 1990s, the prevalence of overweight in children grew from 5% to 11%. 4 Furthermore, Morrison et al 5 showed that much of the increase in body mass index (BMI) in grade school–aged children between the 1970s and 1990 occurred in children between the 50th to 100th percentiles. This increase in the severity of obesity has also translated into an increase in the prevalence of outcomes such as type 2 diabetes mellitus and hypertension. A hospital-based study by Pinhas-Hamiel et al 6 reported a 10-fold increase in the prevalence of newly diagnosed type 2 diabetes mellitus in adolescents from 1982 to 1994. The average BMI in this group was 37 kg/m 2 . Similarly, Leupker et al 7 found a concordant increase in BMI and systolic blood pressure in middle school students, aged 10 to 14 years, from 1986 to 1996.

This association between obesity and hypertension in children has been reported in numerous studies among a variety of ethnic and racial groups, with virtually all studies finding higher blood pressures and/or higher prevalences of hypertension in obese compared with lean children. 8–14 The most comprehensive study by Rosner et al 15 pooled data from 8 large US epidemiological studies involving over 47 000 children to describe the blood pressure differences between black and white children in relation to body size. Irrespective of race, gender, or age, the risk of elevated blood pressure was significantly higher for children in the upper compared with the lower decile of BMI, with an odds ratio of systolic hypertension ranging from 2.5 to 3.7. Freedman et al 12 reported that overweight children in the Bogalusa Heart Study were 4.5 and 2.4 times as likely to have elevated systolic blood pressure and diastolic blood pressure, respectively. Sorof et al 14 recently reported a 3 times greater prevalence of hypertension in obese compared with nonobese adolescents in a school-based hypertension and obesity screening study.

The early clinical course of obesity hypertension appears to be characterized by a preponderance of isolated systolic hypertension (systolic hypertension without diastolic hypertension). Data from a recent multicenter trial of an antihypertensive medication in children showed that among all 140 subjects who enrolled in the trial, 37% had isolated systolic hypertension alone. The prevalence of isolated systolic hypertension was 50% (25/50) in obese subjects compared with 30% (27/90) in nonobese subjects (P=0.02). 16 In the school-based screening for hypertension and obesity by Sorof et al, 14 the prevalence of isolated systolic hypertension among adolescents who were obese and had blood pressure above the 95th percentile on a single set of measurements was 94%. Because isolated systolic hypertension has been shown to be a major risk factor for cardiovascular morbidity and mortality in adults, 17 further investigation of the causes and interventions for this pattern in children is clearly needed.

The classification of weight status into dichotomous categories of “obese” or “nonobese” is clinically useful for characterizing the overall risk of hypertension from obesity. However, these arbitrary percentile-based categories of body habitus preclude more detailed examination of the risk relationship between adiposity and blood pressure. In fact, the risk of hypertension in children increases across the entire range of BMI values and is not defined by a simple threshold effect. Rosner et al 15 reported a linear increase in the prevalence of diastolic hypertension in children of all race, gender, and age combinations as BMI increased across the “normal” range. Similarly, Sorof et al 14 found an increased prevalence of systolic hypertension (based on a single set of measurements) as BMI percentile increased from the 5th to the 95th percentile (Figure 1). Among all demographic and clinical factors analyzed, BMI was most strongly associated with hypertension.

Figure 1. Distribution of BMI percentiles and the prevalence of hypertension within each BMI percentile category. Values above bars indicate number of children within each BMI category. NML indicates normotensive HTN, hypertensive.

The dichotomous classification of blood pressure status into “hypertensive” or “normotensive” is similarly restrictive. Blood pressure is a continuous variable that is positively correlated with cardiovascular risk across the entire blood pressure range. As an example, studies of normotensive and hypertensive children have reported that blood pressure and left ventricular mass index are positively associated across a wide range of blood pressure values. 18–21 Furthermore, elevated left ventricular mass may be present even in children whose blood pressure values fall within the so-called “normotensive” range. Although a child’s current blood pressure may fall within the population-based range of normality, a previously undetected pattern of relative increases in blood pressure across percentile lines over time may still effectively render that patient “hypertensive.” 22 This is consistent with the observation that children with high normal blood pressure during adolescence have a greater tendency to develop hypertension during adulthood. 23

Nonetheless, many health care providers underdiagnose hypertension in children. Unlike in adults, in whom the definition and severity of hypertension are defined by straightforward threshold values based on the risk of outcomes, children require a separate threshold of blood pressure normality at each stage of physical maturity because of the normal age and height-related rise in blood pressure throughout childhood. The most recent Update 24 from the Task Force on Hypertension Control in Children and Adolescents provided population-based percentiles for blood pressure values in children adjusted for age, gender, and height. Values that exceed the 90th and 95th percentiles are defined as “high normal blood pressure” and “hypertension,” respectively. Thus, the identification of the blood pressure threshold for hypertension in a child first requires determination of height percentile, followed by interpretation of a dense table of blood pressure values with a separate threshold for each combination of gender, age, and height percentile. It is important to note that there are no normative blood pressure standards that account for weight or BMI in children. There is compelling evidence that overweight status and elevated blood pressure are closely related and synergistically increase cardiovascular risk. Adjustment of blood pressure norms based on increased weight would therefore inappropriately control for the pathologic influence of overweight on blood pressure.

Because these tables are not always used in everyday practice, mild-to-moderate hypertension may go unrecognized. As an example, although an average sized 10-year-old boy with a persistent systolic blood pressure of 120 mm Hg might not create concern for many primary care physicians, this value exceeds the 95th percentile and thus meets the criteria for hypertension. Although helpful as a guide for the determination of normality, this “statistical” definition of hypertension in children based on population percentiles must ultimately be replaced by an evidence-based definition that links specific levels of blood pressure with outcome.

The accurate measurement of blood pressure in obese children may be particularly challenging because of the absence of blood pressure cuffs that are of appropriate length and width for the upper arm of a small obese patient. Larger-than-appropriate cuff size can give falsely low measurements, whereas a smaller one can give falsely high readings. 25,26 This issue is of particular importance in children because of significant differences in arm sizes at various ages. The most important issue for measuring blood pressure in the obese is choosing the correct cuff-width:arm-circumference ratio. 27 The most recent Update 24 to the Task Force recommends that an appropriate cuff size should have a bladder width that is approximately 40% of the arm circumference midway between the olecranon and the acromion processes (Figure 2).

Figure 2. Diagram of proper placement and selection of blood pressure cuff in children.


Although the majority of data on the pathophysiology of obesity hypertension are derived from studies of animals and adults, the mechanisms of obesity hypertension have been studied in children as well. Most studies of children have focused on investigation of 3 main pathophysiological mechanisms: disturbances in autonomic function, insulin resistance, and abnormalities in vascular structure and function. Although obesity-induced hypertension is likely due to an overlap or combination of these factors, 28 systematic review of the data consistent with each mechanism is useful for understanding how they may contribute to the early stages of the disease process in children.

The link between obesity and hypertension may be mediated in part by sympathetic nervous system (SNS) hyperactivity. This state of hyperactivity may include cardiovascular manifestations such as increased heart rate and blood pressure variability, neurohumeral manifestations such as increased levels of plasma catecholamines, and neural manifestations such as increased peripheral sympathetic nerve traffic. Consistent with the SNS hyperactivity hypothesis, the Bogalusa Heart Study reported that, in a biracial group of children, resting heart rate was positively correlated with blood pressure and subcapsular skinfold thickness 29 and a hyperdynamic cardiovascular state was positively associated with several measures of obesity. 30 Similarly, Sorof et al 14 reported from school-based screening for obesity and hypertension that obese hypertensive adolescents had the highest resting heart rate and nonobese normotensive adolescents had the lowest heart rate (Figure 3). When the analysis was restricted to only those who were hypertensive, a higher heart rate was observed in the obese compared with nonobese adolescents. Rocchini et al 31 found that weight loss, with or without exercise, resulted in a significant reduction in heart rate in obese adolescents.

Figure 3. Heart rate among adolescents at school screening based on weight and blood pressure status. NT indicates normotensive HT, hypertensive O, obese NO, nonobese.

Obese children are also reported to have increased heart rate variability 32 and blood pressure variability 14 compared with nonobese children. Evidence suggests that the increased heart rate variability in obese children may be due to an altered balance between parasympathetic and sympathetic activity and not due exclusively to increased sympathetic activity. Using time- and frequency-domain heart rate variability analysis, 24-hour blood pressure and heart rate monitoring in obese normotensive children has shown an increase in heart rate and in blood pressure associated with decreased parasympathetic heart rate control. 33 Furthermore, physical training in obese children appears to alter autonomic function by reducing the ratio of sympathetic to parasympathetic activity. 34 These data suggest that autonomic function has an important mediating role in the pathogenesis of obesity hypertension in children as well as in adults.

Insulin resistance has been implicated in the pathogenesis of obesity-related hypertension in children. Several studies have reported positive associations between fasting insulin levels and resting blood pressure in obese children and young adults. 35–40 Nonetheless, this association does not necessarily indicate causation. Lughetti et al 41 studied 350 obese children who were categorized as hypertensive or normotensive. Although insulin was significantly higher in hypertensive than in normotensive children, the difference was not clinically relevant. Furthermore, insulin explained only a small amount of systolic and diastolic blood pressure variance, which disappeared after accounting for the confounding effects of age, weight, or other anthropometric dimensions. Weight loss in obese adolescents has also been shown to result in reductions in serum insulin levels and blood pressure 31,42 and to render previously salt-sensitive individuals insensitive to the hypertensive effects of salt-loading. 43 Based on these data, it has been suggested that the insulin resistance associated with obesity may prevent insulin-induced glucose uptake but leave the renal sodium retention effects of insulin relatively preserved, thereby resulting in chronic volume overload and maintenance of blood pressure elevation. However, Csabi et al 44 found no relationship between insulin levels and reduced sodium excretion in obese children. Thus, a causal role of insulin resistance in the pathogenesis of obesity hypertension remains uncertain.

Altered vascular structure and function may also contribute to the pathogenesis of obesity hypertension. Ultrasound of the carotid artery has demonstrated increased intimal-medial thickness in diabetic children 45,46 and children with familial hypercholesterolemia, 47–49 compared with normal controls. In addition, decreased vascular compliance has been reported in diabetic children 50 and children with familial hypercholesterolemia. 51 Similar vasculopathy has been found in obese children, in whom less severe metabolic disturbances such as glucose intolerance and dyslipidemia are common. Tounian et al 52 reported lower arterial compliance, lower distensibility, and lower endothelium-dependent and -independent function in severely obese compared with control children. Similarly, Rocchini et al demonstrated decreased maximal forearm blood flow and increased minimum forearm vascular resistance in obese adolescents, 53 which was improved after weight loss. 54

Although these data have provided insight into the potential mechanisms of obesity hypertension in children, truly mechanistic studies illustrating the pathophysiology of the early stages of the disease process have yet to be performed. To some extent, the vulnerability of the pediatric population from a research standpoint has been a barrier to performing studies such as neurography to measure peripheral sympathetic nerve traffic or interventional studies such as hyperinsulinemic euglycemic clamping. However, the acuity of the problem would argue for an expanded role for mechanistic studies in children to identify therapeutic interventions that may interrupt the disease process before the establishment of potentially irreversible sequelae.

Cardiovascular Risk Factors and Complications

The complications of obesity that are associated with cardiovascular disease include hypertension, dyslipidemia, insulin resistance, glucose intolerance, type 2 diabetes mellitus, left ventricular hypertrophy, and pulmonary hypertension resulting from obstructive sleep apnea. 55 Many of these outcomes of obesity have traditionally been viewed as problems of adulthood. However, further study has revealed that many of these abnormalities may begin in childhood and adolescence.

Obesity in children has been associated with the development of early myocardial changes and coronary and carotid artery pathology. Kortelainen evaluated the autopsies of 210 children aged 5 to 15 years who had suffered a violent death. 56 Ponderal index was a significant predictor of heart weight and the presence of coronary artery intimal fatty streaks. Similarly, Berenson et al 57 demonstrated in the Bogalusa Heart Study that children and young adults who died primarily of trauma showed an association between BMI, systolic blood pressure, diastolic blood pressure, and the presence of fatty streaks and fibrous plaques in the aorta and coronary arteries at autopsy. Gidding et al 58 studied by electron beam computed tomography 29 patients aged 11 to 23 years with familial hypercholesterolemia to evaluate the presence of coronary artery calcium. Coronary artery calcium deposits were found in 7 of 29 subjects and were associated with increased body mass index. Sorof et al 59 measured carotid intimal-medial thickness by duplex vascular ultrasound in children and adolescents with essential hypertension to assess for evidence of early arterial changes. Carotid intimal-medial thickness was positively correlated with weight, BMI, and left ventricular mass index, but not with height or age.

Left ventricular hypertrophy has been shown to be an independent risk factor for cardiovascular disease morbidity and mortality. 60 In children and adolescents, left ventricular mass is determined by body size, assessed both by growth (height) and weight (adiposity). Urbina et al 61 reported that the major factor influencing left ventricular mass in the Bogalusa Heart Study was linear growth determined by height, but that measures of ponderosity were also significant determinants of LVM. Daniels et al 21 reported that lean body mass was the strongest determinant of LVM, but that fat mass and systolic blood pressure were also significant predictors of LVM. In adolescents with essential hypertension, Daniels et al 62 found severe LVH in 14% of subjects, with greater body mass index one of the major factors associated with increased LVM. A recent study of 115 children undergoing evaluation for hypertension found an overall prevalence of LVH of 38%. 63 This shows that LVH can occur early in the course of hypertension in young individuals. Patients with LVH were heavier and had greater BMI than those without LVH, and LVMI was positively correlated with BMI. These findings suggest that the combination of obesity, hypertension, and other risk factors for cardiovascular disease presents a particularly adverse profile for ultimate cardiovascular outcomes.

Obesity early in life appears to increase the likelihood of clustering of cardiovascular risk factors. In a study of adolescent girls, Morrison et al 64 found that almost 11% of overweight white girls and 65% of overweight black girls had three cardiovascular risk factors compared with an expected frequency of 0.8%. Similar findings were reported for boys. 65 The distribution of fat may also be important. Daniels et al 21 evaluated the effects of fat distribution on risk factors for cardiovascular disease in adolescents. A more central deposition of fat (android pattern) was associated with elevation of triglycerides, decreased HDL cholesterol, increased systolic blood pressure, and increased LV mass. These relationships persisted after controlling for other variables such as age, race, gender, and height. The most compelling evidence of cardiovascular risk factor clustering in youth comes from the Bogalusa autopsy study, in which subjects with 0, 1, 2, and 3 or 4 risk factors had, respectively, 19.1%, 30.3%, 37.9%, and 35.0% of the intimal surface covered with fatty streaks in the aorta. 57


Most interventions for pediatric obesity have focused on behavioral approaches to diet and physical activity to address the main components of energy balance. Although these approaches have been shown to have both short- and long-term beneficial effects on BMI in selected patients, 66 such success has not been uniform. This management approach is very labor intensive and is often not covered by medical insurance. 67 Other dietary approaches which have been tried include the very low calorie diet 68 and the protein-modified fast. 69 Although these dietary approaches can be effective in selected patients, they have also been associated with important adverse effects. Surgical approaches have been used in morbidly obese adolescents but are clearly not appropriate for a large number of patients.

The role of pharmacological management in the management of pediatric obesity has been controversial. The history of pharmacological treatment of obesity in adults is replete with problems, and there have been few well-controlled studies to show that the available drugs are well tolerated and effective for use in obese children. Many of the drug treatments that have been tried in adults have resulted in complications such as with amphetamines and fenfluramine/dexfenfluramine. This history has reinforced the debate regarding whether medications should be used to treat obesity except under the most extreme circumstances. On the one hand, obesity is a chronic problem requiring long-term management and potentially long-term exposure to the adverse effects of medications, an issue of particular concern in growing and developing children. On the other hand, evidence for the benefits of weight loss on blood pressure in children may tilt the risk-benefit balance in favor of a more aggressive management approach for the prevention of future cardiovascular disease. One medication that is currently being evaluated for treatment of obesity in adolescents is sibutramine, an inhibitor of the reuptake of serotonin and norepinephrine. However, the safety and efficacy of sibutramine in patients under 16 years of age is still unknown. Furthermore, sibutramine may be associated with increased blood pressure in some patients and is not recommended for use in patients with a history of hypertension. Orlistat is a gastrointestinal lipase inhibitor that may hold promise for safe and effective pharmacological treatment for childhood obesity.

The benefits of weight loss on blood pressure reduction in children have been investigated in both observational and interventional studies. In a retrospective study based on a 10-year period of observation, Clarke et al 70 reported that children whose ponderosity increased over that period had a relative increase in blood pressure by 18 percentiles compared with their peers, whereas children whose ponderosity decreased had a relative reduction in blood pressure by 13 percentiles. The positive effect of weight loss on blood pressure in children has also been demonstrated in several interventional studies. One of the first such studies by Brownell et al 71 reported blood pressure reductions of up to 16/9 mm Hg in obese children who achieved significant weight reduction after 16 months of dietary counseling. Figueroa-Colon et al 72 found that blood pressure was significantly reduced compared with baseline at all points of a study comparing 2 hypocaloric dietary modifications in obese children. Wabitsch et al 42 reported a blood pressure reduction of 9/5 mm Hg associated with a weight reduction of 8.5 kg after a 6-week dietary intervention in obese adolescent girls. Similarly, Gallistl et al 73 reported an 8/7 mm Hg blood pressure reduction associated with weight loss of 3.9 kg after a 3-week diet and exercise program in obese children.

Although these studies suggest that blood pressure reductions are induced by weight loss in obese children, each is limited by the absence of a matched control group to show that the blood pressure reduction was directly attributable to weight loss. The only controlled trial to date was performed by Rocchini et al 54 who randomized overweight adolescents to 3 interventions over a 20-week period: diet alone, diet plus exercise, and control (no intervention). Changes in systolic blood pressure from baseline in the diet plus exercise group, diet alone group, and control group were −16 mm Hg, −10 mm Hg, and +4 mm Hg, respectively. This latter study provides the most definitive evidence that weight loss, particularly in conjunction with exercise, can be beneficial in the management of obesity hypertension in children. However, the long-term benefits of weight loss on blood pressure remain to be defined because it is unknown whether the decline of blood pressure observed during acute weight loss is maintained.


The prevalence and severity of obesity is increasing in children and adolescents. These observations suggest that the trend of decreasing cardiovascular disease in adults observed over the past 50 years may be reversed as the current population of overweight children and adolescents become adults. 74 At present, treatment for all overweight children and adolescents can be recommended based on available data. However, the methods used to achieve weight management remain controversial. It seems appropriate to reserve pharmacological therapy for children most severely affected by obesity and its sequelae. It is also appropriate to reserve such therapy for those who have failed or have had only modest success with behavioral therapy directed at dietary modification and increased physical activity. The presence of ongoing obesity-related outcomes such as hypertension, diabetes mellitus or impaired glucose tolerance, and dyslipidemia may increase the rationale for more aggressive therapy. Ultimately, multiple therapeutic strategies may be necessary to achieve the desired goal.

Obesity in childhood should be considered a chronic medical condition and, thus, is likely to require long-term treatment. Public health initiatives to educate community leaders and health care providers may prove instrumental in stemming the evolving epidemic of pediatric obesity and its complications. In addition, the scope and acuity of the problem facing our youth suggests that substantial research is needed that is focused on the mechanisms of hypertension related to obesity in the pediatric population. Such research will serve as the basis for future guidelines for prevention and treatment of obesity hypertension.



Menopause and its associated decline in oestrogen is linked to chronic conditions like cardiovascular disease and osteoporosis, which may be difficult to disentangle from the effects of ageing. Further, post-menopausal women are at increased risk of cerebrovascular disease, linked to declines in cerebral blood flow (CBF) and cerebrovascular reactivity (CVR), yet the direct understanding of the impact of the menopause on cerebrovascular function is unclear. The aim of this systematic review and meta-analysis was to examine the literature investigating CBF and CVR in pre- compared with post-menopausal women


Five databases were searched for studies assessing CBF or CVR in pre- and post-menopausal women. Meta-analysis examined the effect of menopausal status on middle cerebral artery velocity (MCAv), and GRADE-assessed evidence certainty


Nine studies (n=504) included cerebrovascular outcomes. Six studies (n=239) reported negligible differences in MCAv between pre- and post-menopausal women [2.11cm/s (95% CI: -8.94 to 4.73, p=0.54)], but with a “low” certainty of evidence. MCAv was lower in post-menopausal women in two studies, when MCAv was adjusted for blood pressure. CVR was lower in post- compared with pre-menopausal women in two of three studies, but high-quality evidence is lacking. Across outcomes, study methodology and reporting criteria for menopause were inconsistent


MCAv was similar in post- compared with pre-menopausal women. Methodological differences in characterising menopause and inconsistent reporting of cerebrovascular outcomes make comparisons difficult. Comprehensive assessments of cerebrovascular function of the intra- and extracranial arteries to determine the physiological implications of menopause on CBF with healthy ageing is warranted.

40.4: Blood Flow and Blood Pressure Regulation - Biology

The peripheral circulation was studied in 19 lumberjacks and in 12 control subjects. Twelve of the lumberjacks were free from vascular symptoms and seven had vibration induced white finger (VWF). Using the strain-gauge plethysmographic technique, the digital circulation was examined at rest, during cooling of the upper body, and during heating of the upper body. At rest and during vasodilatation no significant differences were found between the lumberjacks and the controls. During reflexive vasoconstriction, digital blood flow in the upper body was more reduced in lumberjacks with VWF than in control subjects. Furthermore, digital blood pressure of the lumberjacks with VWF fell more than in the control group. The peripheral resistance also increased more, but this difference was not statistically significant. There was no evidence that the exaggerated vasoconstriction of VWF resulted from a narrowing of the lumen of arterioles due to hypertrophy of the vessel wall. The present findings suggest that VWF is produced by the highly sensitive responsiveness of the affected vessel to normal vasoconstrictor stimuli.

Gabriel Dutra is studying Computer Science at Drew University. Dutra conducted statistical analysis of text data and developed the path-minimizing algorithm.

Ji Hoon Kim is pursuing a dual degree of Physics B.A. from Drew University and Applied Physics B.S. from Columbia University. Kim conducted the pilot study using the physics textbook.

Peiyu Guo graduated from Drew University with a B.A. in Computer Science. Guo collected data and conducted statistical analysis.

Kayla Rockhill is studying Physics and Mathematics at Drew University. Rockhill collected data.

Minjoon Kouh is an associate professor of Physics and Neuroscience at Drew University. Kouh designed and supervised the overall analysis and wrote the paper. He is the corresponding author.

This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.

Future perspectives

The future will witness increasing interest in finding reliable methods of testing endothelial function several large noninvasive studies are needed to determine the predictive value of brachial ultrasound testing as a potential predictor of cardiovascular disease. As the measures of endothelial dysfunction become clinically applicable, this may translate into improved methods of risk assessment that help in predicting, preventing, and treating cardiovascular disease. Inflammatory markers, such as C-reactive protein, will probably find their way into risk assessment several therapeutic strategies aimed at improving endothelial function in a variety of cardiovascular disease states are under investigation. The future holds great promise.

Watch the video: The Pathway of Blood Flow Through the Heart, Animation. (August 2022).